Axogen Inc (AXGN) Inventory Turnover Ratio, from second quarter 2026 to second quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 
Axogen inc   (NASDAQ: AXGN)
 

Axogen Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Axogen Inc inventory turnover ratio, the Axogen Inc 's ability to sell and replace its inventory in the second quarter 2026, sequentially increased to 1.45 in the second quarter 2026, AXGN's markets remain strong, its supply chain continue to be in a grate shape.Average inventory processing period, for the Axogen Inc in Jun 30 2026 quarter, has decreased to 252 days, compare to 253 days, in the Mar 31 2026 quarter.

Within Healthcare sector 267 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 1136 in the first quarter 2026, to 1728.

AXGN Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Axogen Inc Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

AXGN Inventory Turnover Ratio (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Inventory Growth 28.66 % 29.77 % 27.69 % 38.2 % 31.27 %
Y / Y Cost of Sales Growth 30.14 % 12.04 % 30.98 % 15.43 % 16.53 %
Inventory Turnover Ratio (TTM) 1.45 1.44 1.49 1.48 1.55
AXGN's Total Ranking # 1728 # 1136 # 1283 # 1081 # 1495
Average inventory processing period 252 254 245 246 235
Seq. Inventory Growth 2.69 % 8.73 % 4.42 % 10.35 % 3.58 %
Seq. Cost of Sales Growth 24.82 % -1.46 % 9.98 % -3.79 % 7.46 %




Inventory Turnover Ratio Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 120
Healthcare Sector # 268
Overall Market # 1728

Inventory Turnover Ratio Statistics
High Average Low
1.83 1.31 0.65
(Jun 30 2021)   (Sep 30 2012)



AXGN Company Profile >> Back to AXGN Efficiency Comparisons >> Compare AXGN Inventory Turnover Ratio to its Competitors

Financial Statements
Axogen Inc 's Inventories $ 47 Millions Visit AXGN's Balance sheet
Axogen Inc 's Cost of Revenues TTM $ 64 Millions Visit AXGN's Income Statement
What are AXGN's Sales? Visit AXGN's Sales by Segment

Other Inventory Turnover Ratios
Axogen Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Medical Equipment & Supplies Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
AXGN's Inventory Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for AXGN's Competitors
Inventory Turnover Ratio for AXGN's Suppliers
Inventory Turnover Ratio for AXGN's Customers

You may also want to know
AXGN's Sales Growth Rates AXGN's Pe Price to earnings ratio AXGN's Receivables Turnover Ratio AXGN's Stock Quote
AXGN's Net Income Growth Rates AXGN's Ps Price to Sales ratio AXGN's Sales per Employee AXGN's Asset Turnover Ratio
AXGN's Net Margin AXGN's Pb Price to Book ratio AXGN's Financial Strength Ratios AXGN's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Jun 30 2026 Inventories at quarter ending Jun 30 2026
Biocryst Pharmaceuticals Inc   3.69 $ 20.926  Millions$ 6  Millions
Abbvie Inc   3.66 $ 18,365.000  Millions$ 5,016  Millions
Teva Pharmaceutical Industries Limited  3.66 $ 8,232.000  Millions$ 2,250  Millions
Neuraxis Inc   3.55 $ 0.783  Millions$ 0  Millions
Beyond Air Inc   3.51 $ 6.447  Millions$ 2  Millions
Nexgel Inc   3.49 $ 7.577  Millions$ 2  Millions
Lifeward ltd   3.47 $ 13.976  Millions$ 4  Millions
Tandem Diabetes Care Inc   3.46 $ 456.703  Millions$ 132  Millions
Baxter International Inc   3.46 $ 8,020.000  Millions$ 2,317  Millions
Mirum Pharmaceuticals Inc   3.40 $ 85.221  Millions$ 25  Millions
Zai Lab Limited  3.39 $ 195.542  Millions$ 58  Millions
Cadre Holdings inc   3.39 $ 399.991  Millions$ 118  Millions
Bausch Health Companies Inc   3.38 $ 3,783.000  Millions$ 1,120  Millions
Bellevue Life Sciences Acquisition Corp  3.38 $ 1.215  Millions$ 0  Millions
Evolus Inc   3.37 $ 105.904  Millions$ 31  Millions
Gilead Sciences Inc   3.35 $ 6,217.000  Millions$ 1,857  Millions
10x Genomics Inc   3.29 $ 184.539  Millions$ 56  Millions
Exelixis Inc   3.28 $ 85.665  Millions$ 26  Millions
Biofrontera Inc   3.28 $ 6.622  Millions$ 2  Millions
Becton Dickinson And Company  3.25 $ 11,161.000  Millions$ 3,429  Millions
Maravai Lifesciences Holdings Inc   3.22 $ 135.038  Millions$ 42  Millions
Solventum Corporation  3.22 $ 3,421.000  Millions$ 1,061  Millions
Agilent Technologies inc   3.20 $ 3,404.000  Millions$ 1,064  Millions
Mettler toledo International Inc   3.18 $ 1,277.460  Millions$ 401  Millions
Bionexus Gene Lab Corp   3.15 $ 2.362  Millions$ 1  Millions
Zevra Therapeutics Inc   3.14 $ 6.180  Millions$ 2  Millions
Prestige Consumer Healthcare Inc   3.13 $ 513.522  Millions$ 164  Millions
Eton Pharmaceuticals Inc   3.11 $ 44.176  Millions$ 14  Millions
Iovance Biotherapeutics inc   3.09 $ 167.681  Millions$ 54  Millions
Mimedx Group Inc   3.07 $ 75.981  Millions$ 25  Millions

Date modified: 2026-10-05T11:03:41+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.